Nevro Corp Stock News

Nevro Corp. (NYSE:NVRO), might not be a large cap stock, but it led the NYSE gainers with a relatively large price...

Nevro (NVRO) delivered earnings and revenue surprises of 26.67% and 36.02%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced its financial results for the second

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...

Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in,...

Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Small-Cap Growth Fund posted a return of 34.59% for the quarter, outperforming its benchmark, t

Nevro (NVRO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the Company will release its fi

Stocks Analysis by Contrarian Outlook (Michael Foster) covering: S&P 500, Microsoft Corporation, Apple Inc, Amazon.com Inc. Read Contrarian Outlook (Michael Foster)'s latest article on Investing.com

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market

Investor confidence is high on Nevro (NVRO), thanks to solid prospects

AQR Capital Management LLC lifted its holdings in Nevro Corp (NYSE:NVRO) by 49.2% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 13,922 share

Maverick Capital Ltd. acquired a new position in Nevro Corp (NYSE:NVRO) during the first quarter, Holdings Channel.com reports. The firm acquired 9,180 shares of the medical equipment provider’s sto

Deutsche Bank AG raised its holdings in Nevro Corp (NYSE:NVRO) by 100.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The ins

Researchers have shed light on the practical advantages of high-intensity interval training (HIIT) or short bursts of all-out exercise for people who have experienced spinal cord injuries (SCI).